Drug Can Slow Bone Loss in Prostate Cancer Patients

Related Encyclopedia • Adenocarcinoma of the Lung and Brain Metastases • Animal Bites • Ankylosing Spondylitis • Anterior Cruciate Ligament Repair More... Related Healthscout Videos Silent Killer Joint Attack Sun Damaged Complementary Cancer Care More... Related Animations • Breast Self-Exam Video • Colon Cancer • Erectile Dysfunction • Osteoporosis Basics More... Related Drug Information • Cialis • Epogen • Flomax • Iressa More... Related News Articles • Meat, Dairy Won't Up Odds for Breast Cancer • Colon Cancer Stopped in Its Tracks in Swiss Study • Scans Shed New Light on Concussions • Whole Grains, Bran May Fight Hypertension in Men More...

Page:  << Prev | 1 | 2 | 3

Based on the findings, the team advised that alendronate treatment be prescribed for prostate cancer patients at the same time ADT is commenced.

Dr. Matthew Smith, director of genitourinary medical oncology at Massachusetts General Hospital Cancer Center, Boston, said that while the current study is "beautiful work," more focused research is needed, given that fracture risk is an "underappreciated problem."

"There have already been a number of studies looking at drugs to increase bone density," Smith said. "So this is not a criticism of this study, but I have to say that, really, what we need now are large long-term studies that look at how to prevent fractures in men. We want high-level evidence for any intervention that we do, and we haven't had that so far."

Text Continues Below

---

More information

There's more on osteoporosis in men at the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Page:  << Prev | 1 | 2 | 3